Evidence map›Paper›PMID 37285330›Full record

ReviewThe American journal of case reports2023

Rare Case of Refractory Hypokalemia in a Patient with Acute Monocytic Leukemia.

Minha Naseer, Brooke Kania, Moutaz Ghrewati, Anas Mahmoud, Beenish Faheem, Monisha Singhal

Open access · hybridAbstract readReviewCase Reports
In one paragraph

Review in The American journal of case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Minha NaseerDepartment of Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.
Brooke KaniaDepartment of Medicine, Robert Wood Johnson Medical School, New Brunswick, NJ, USA.ORCID 0000-0002-7873-1888
Moutaz GhrewatiDepartment of Hematology-Oncology, St. Joseph's University Medical Center, Paterson, NJ, USA.
Anas MahmoudDepartment of Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.
Beenish FaheemDepartment of Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.
Monisha SinghalDepartment of Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.
St. Joseph’s University Medical Center · USJohnson University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Refractory hypokalemia has been rarely demonstrated in patients with acute monocytic leukemia (AMoL). Hypokalemia develops in these patients owing to renal tubular dysfunction, secondary to lysozyme enzymes that are released by monocytes in AMoL. Additionally, renin-like substances are produced from monocytes and can lead to hypokalemia and metabolic alkalosis. There is also an entity called spurious hypokalemia, in which high numbers of metabolically active cells in blood samples increase sodium-potassium ATPase activity, resulting in influx of potassium. Additional research is warranted regarding this specific demographic to create standardized treatment approaches to electrolyte repletion. CASE REPORT In this case report, we demonstrate a rare case of an 82-year-old woman with AMoL, complicated by refractory hypokalemia, who presented with concerns of fatigue. The patient's initial laboratory results were significant for leukocytosis with monocytosis and severe hypokalemia. Refractory hypokalemia was noted, despite administration of aggressive repletions. During her hospitalization, AMoL was diagnosed and an extensive workup was performed to evaluate the underlying cause of hypokalemia. Ultimately, the patient died on day 4 of hospitalization. We describe the correlation between severe refractory hypokalemia and leukocytosis and provide a literature review of multiple etiologies of refractory hypokalemia in patients with AMoL. CONCLUSIONS We evaluated the numerous pathophysiologic mechanisms responsible for refractory hypokalemia in patients with AMoL. Our therapeutic outcomes were limited owing to the patient's early death. It is of high importance to evaluate the underlying cause of hypokalemia in these patients and to treat accordingly with caution.

Indexed as

HypokalemiaLeukemia, Monocytic, AcuteAged, 80 and overFemaleHumansLeukocytosisPotassiumPotassium

Identifiers

PMID37285330
PMCPMC10259269
OpenAlexW4367554696

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.